GILD Stock 12 Month Forecast Average Price Target $99.29 ▲(8.34% Upside) Based on 26 Wall Street analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $99.29 with a high forecast of $125.00 and a low forecast of $73.00. The ave...
Analyst Price Target is $98.39 ▲ +2.45% Upside Potential This price target is based on 27 analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $98.39, with a high forecast of $125.00 and a low forecast of $69.00. The average ...
KTE-X19 and product candidates evaluated for advanced fibrosis due to nonalcoholic steatohepatitis and under Gilead’s HBV cure program; Gilead’s ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or othe...
safety and efficacy data from clinical studies may not warrant further development of Gilead’s product candidates, including GS-0976; Gilead’s ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market cond...